Evommune EVMN
NYSE EVMN
$5.28 +0.11 (+2.03%)
As of: Oct 22, 2026 · 11:46 AM EDT

Evommune (EVMN) EPS (Basic) (2024 - 2026)

Updated

Evommune's EPS (Basic) came in at -$0.89 for Q2 2026, compared with -$8.80 a year earlier.

Analysis

Evommune (EVMN) EPS (Basic) (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Evommune reported EPS (Basic) of -$2.62; for FY2025, it was -$11.22.

  • Going back by year, EPS (Basic) was -$44.29 in FY2024.
  • The five-year range for quarterly EPS (Basic) is -$13.74 (Q4 2024) to -$0.64 (Q1 2026).
  • Business Quant data shows EVMN's EPS (Basic) at -$0.64 (Q1 2026), -$4.61 (Q4 2025) and -$8.07 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,170.58 Bn 1,139.17 Bn 19.71 Bn 7.95
2 Johnson & Johnson 639.26 Bn 557.79 Bn 17.26 Bn 2.30
3 AbbVie 501.86 Bn 474.97 Bn 12.70 Bn 2.04
4 Merck 374.72 Bn 329.10 Bn 12.21 Bn -0.54
5 Novartis Ag 302.72 Bn 266.71 Bn 11.24 Bn 1.68
6 Astrazeneca 268.40 Bn 242.08 Bn 12.86 Bn 1.62
7 Amgen 242.11 Bn 197.51 Bn 7.24 Bn 4.40
8 Gilead Sciences 193.45 Bn 167.65 Bn 6.22 Bn -8.44
9 Pfizer 172.31 Bn 118.96 Bn 10.94 Bn -0.04
10 Evommune 190.62 Mn -446.90 Mn - -0.89
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.89
Mar 31, 2026 -0.64
Dec 31, 2025 -4.61
Sep 30, 2025 -8.07
Jun 30, 2025 -8.80
Mar 31, 2025 -9.48
Dec 31, 2024 -13.74
Sep 30, 2024 -10.47
API Access

Evommune EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=EVMN&period=max&api_key=YOUR_API_KEY